US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Assertio Holdings, Inc.

News headline image
Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Provides Update on Garda Therapeutics Tender Process
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Announces Agreement to be Acquired by Garda Therapeutics
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT
News headline image
Assertio Reports Third Quarter 2025 Financial Results
From Assertio Holdings, Inc.
Via Business Wire
Tickers ASRT